Soluble amyloid b-peptide oligomers (AbOs), increasingly recognized as causative agents of Alzheimer's disease (AD), disrupt neuronal Ca 2+ homeostasis and synaptic function. Here, we report that AbOs at sublethal concentrations generate prolonged Ca 2+ signals in primary hippocampal neurons; incubation in Ca 2+ -free solutions, inhibition of ryanodine receptors (RyRs) or N-methyl-d-aspartate receptors (NMDARs), or preincubation with N-acetyl-l-cysteine abolished these signals. AbOs decreased (6 h) RyR2 and RyR3 mRNA and RyR2 protein, and promoted mitochondrial fragmentation after 24 h. NMDAR inhibition abolished the RyR2 decrease, whereas RyR inhibition prevented significantly the RyR2 protein decrease and mitochondrial fragmentation induced by AbOs. Incubation with AbOs (6 h) eliminated the RyR2 increase induced by brain-derived nerve factor (BDNF) and the dendritic spine remodeling induced within minutes by BDNF or the RyR agonist caffeine. Addition of BDNF to neurons incubated with AbOs for 24 h, which had RyR2 similar to and slightly higher RyR3 protein content than those of controls, induced dendritic spine growth but at slower rates than in controls. These combined effects of sublethal AbOs concentrations (which include redox-sensitive stimulation of RyR-mediated Ca 2+ release, decreased RyR2 protein expression, mitochondrial fragmentation, and prevention of RyR-mediated spine remodeling) may contribute to impairing the synaptic plasticity in AD.
Introduction

A
lzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by progressive memory loss that leads inevitably to severe dementia. Numerous reports have linked the pathogenesis of AD, the most frequent cause of dementia worldwide, with the accumulation and aggregation of amyloid beta (Ab)-peptide in the brain (27, 46) ; for a review, see (29) . Although Ab monomers are not neurotoxic, local peptide accumulation favors self-association and generation of different Ab aggregates that include insoluble Ab fibrils and soluble Ab oligomers, which have been proven toxic to neurons and other brain cell types (25, 42, 57, 73) . Insoluble Ab fibrils, resembling those found in amyloid plaques, are neurotoxic at micromolar concentrations both in vitro and in vivo (44, 57) . Even more relevant to AD pathology is the fact that soluble Ab oligomers (hereafter referred to as AbOs) accumulate specifically in AD human brain and cerebrospinal fluid and act as potent and diffusible neurotoxins (42) . AbOs associate with synapses (41) and cause a swift increase in intracellular Ca 2þ concentration ([Ca 2þ ]) (14, 17) , but the contribution of Ca 2þ -induced Ca 2þ release (CICR) from intracellular stores to this [Ca 2þ ] increase has not been investigated in depth. AbOs also impair Ca 2þ -dependent neuronal functions, increasing tau hyperphosphorylation (16) , oxidative stress (14) , and excitotoxicity (1a) . Significantly, AbOs interfere with synaptic plasticity and inhibit long-term potentiation (LTP), a classic paradigm of memory-associated synaptic mechanisms (42, 73) . Functional and morphologic deterioration of synapses by AbOs strongly associate with memory loss in AD (15, 41, 43, 63) .
A regulated increase in intracellular [Ca 2þ ] plays key roles in hippocampal synaptic plasticity, whereas disruption of neuronal Ca 2þ homeostasis is likely to result in neuronal 1 death (28, 50) . Alterations of Ca 2þ homeostasis by AbOs have been implicated in AD pathogenesis (14, 17) ; for recent reviews, see (7, 8) . Similarly, amyloid precursor protein (APP) (25) or presenilin mutations associated with familial AD may compromise the normal Ca 2þ -regulating functions of plasma membrane APP or of endoplasmic reticulum (ER)-resident presenilins or both (8) .
The three known mammalian RyR isoforms (RyR1, RyR2, and RyR3) are present in mammalian brain (24, 77) . Several reports indicate that RyR-mediated Ca 2þ release contributes to the defective Ca 2þ homeostasis that accompanies AD pathogenesis. The N-terminus of presenilin-2 increases singlechannel activity of brain RyR through direct protein-protein interactions (31) . Downregulation of RyR expression, especially of the RyR2 isoform, occurs very early in human AD brain postmortem samples (36) , whereas upregulation of RyR3 expression and altered Ca 2þ signaling have been suggested to occur in different AD transgenic mouse models (65, 66) . Moreover, extracellular Ab leads to increased RyR3 expression in primary cortical neurons (66) , whereas treatment of cortical neurons with Ab fibrils promotes ER Ca 2þ release through RyR and inositol 1,4,5-trisphosphate receptors, inducing ER stress, oxidative stress, and cell death (20, 60) .
Many studies have established that sustained hippocampal neuronal plasticity entails generation and growth of dendritic spines (38) . These morphologic changes are mediated by brain-derived neurotrophic factor (BDNF) (13, 67) , a neurotrophin synthesized and released from neurons in an activitydependent manner (40) . On binding to TrkB receptors, BDNF stimulates several intracellular signaling cascades, including calcium-dependent kinase pathways (3, 71) that contribute to inducing and maintaining hippocampal LTP (58) . Soluble AbOs, which are known to disrupt synaptic plasticity, decrease BDNF mRNA levels and compromise BDNF-induced intracellular signaling (23, 68, 69) .
In view of the key roles played by both RyR and BDNF in synaptic plasticity (4, 22, 33, 35, 67) and their potential effects on AD pathology, we studied here the possible effects of AbOs on the generation of RyR-mediated Ca 2þ signals, RyR expression, and BDNF-induced dendritic spine remodeling. Our results suggest that AbOs, through stimulation of RyRmediated Ca 2þ release, engage Ca 2þ -dependent pathways that downregulate RyR expression, thus preventing RyRdependent spine growth induced by BDNF or caffeine. We propose that sustained stimulation of RyR-mediated Ca 2þ release by AbOs represents a significant factor in the synaptotoxicity and synaptic plasticity defects induced by AbOs.
Experimental Procedures
Materials
Ab peptide (Ab 1-42 ) was purchased from Bachem Inc. (Torrance, CA), and BDNF, from Chemicon Millipore (Billerica, MA). Fluo4-AM, calcein-AM, the Live/Dead viability kit for mammalian cells, ProLong, Alexa Fluor 488 anti-rabbit, and Alexa Fluor 635 anti-mouse were from Molecular Probes, Inc. (Eugene, OR). Trizol reagent was from Invitrogen (Carlsbad, CA). Hexafluoro-2-propanol (HFIP) was from Merck (Darmstadt, Germany); B27 supplement and Neurobasal medium were from Gibco (Carlsbad, CA). Rabbit antiRyR3 and mouse anti-MAP2 were from Chemicon (Temecula, CA), mouse anti-RyR2 and mouse anti-mHSP70 from Pierce Biotechnology (Rockford, IL), monoclonal anti-b À actin from Sigma (St. Louis, MO), anti-glial fibrillary acidic protein (GFAP) from DAKO (Carpinteria, CA), rabbit anti-Drp-1 from Thermo Scientific (Rockford, IL), mouse anti-cytochrome c from BD Biosciences (San Jose, CA), and rabbit anti-COX IV from Cell Signaling (Danvers, MA). DNA-free Kit was obtained from Ambion (Austin, TX). ImProm-IIReverse Transcriptase kit was from Promega (Madison, WI), the DNA-binding dye SYBR green (Platinum SYBR Green qPCR SuperMix UDG) was from Invitrogen, and PDVF membranes from Millipore. BAPTA and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) were from Sigma Chemical, and ionomycin, from Calbiochem (La Jolla, CA).
Preparation of AbOs and Ab fibrils
The Ab peptide, prepared as a dried hexafluore-2-propanol (HIFP) film, as described previously (14) , was stored at À808C for up to 4 months. Before use, this peptide film was dissolved in sufficient sterile DMSO to make a 5 mM stock solution. To prepare AbOs by using standard methods (41), the 5 mM peptide solution was subsequently diluted to 100 mM with cold phosphate-buffered saline (PBS), aged overnight at 48C, centrifuged at 14,000 g for 10 min at 48C to remove insoluble aggregates (protofibrils and fibrils), and the supernatant containing soluble AbOs was transferred to clean tubes and stored at 48C. The oligomeric state of AbO preparations was confirmed by Western blot and HPLC analysis, as described (14, 72) . Only fresh AbO preparations (1 day old) were used in all experiments. For preparation of Ab fibrils, the 5 mM stock solution of Ab peptide was diluted 50-fold in 10 mM HCl in PBS, immediately vortexed for 30 s, and incubated for 24 h at 378C as described (14) . To check the uniformity of AbO and Ab fibril preparations, 5 ml of a solution containing 10 mM AbOs or 10 mM Ab fibrils was applied to Formvar-coated grids, and after 1 min, were washed twice with filtered water. Samples were negatively stained with filtered 2% uranyl acetate for 1 min and imaged by transmission electron microscopy in a Zeiss EM-109 microscope at 80 kV. Supplementary Figure S1A illustrates a representative electron micrograph of an AbO preparation, showing abundant oligomers with the classic spherical morphology previously described (17, 42) and with an average diameter of *6 nm (Supplementary Data are available online at www.liebertonline.com/ars). Ab fibrils, which were not observed in fresh AbO preparations, were also successfully generated ( Supplementary Fig. S1B ).
Primary hippocampal cultures
Cultures were prepared from 18-day-old embryos obtained from pregnant Sprague-Dawley rats, as previously described (52) . In brief, brains were removed and placed in a dish containing Hanks-glucose solution. Hippocampi were dissected and, after stripping away meninges membranes, cells were gently dissociated in Hanks-glucose solution, centrifuged, and resuspended in DMEM medium supplemented with 10% horse serum. Dissociated hippocampal neurons were plated on polylysine-coated plates, and after 1 h, DMEM was replaced by Neurobasal medium supplemented with B-27. Cells were incubated for 15 to 21 days in vitro (DIV) at 378C in a humidified 5% CO 2 atmosphere before experimental manip-ulations. These mature cultures were substantially enriched in neuronal cells, as revealed by immunocytochemistry (Supplementary Fig. S1C ), and expressed both RyR2 and RyR3 in neurites and cell bodies (Supplementary Fig. S1D and E).
Immunocytochemistry
Hippocampal cultures (21 DIV) were fixed by adding an equal volume of 4% formaldehyde (in PBS buffer) for 5 min. After this solution was replaced with 4% formaldehyde, cultures were incubated for 10 min, rinsed 3 times with PBS, incubated with 10% normal goat serum plus 0.1% Triton X-100 (blocking-permeant solution) for 1 h, and then immunolabeled by overnight incubation at 48C with different antibodies diluted in blocking solution. Rabbit anti-RyR3 (1:30,000), mouse anti-RyR2 (1:30,000), mouse anti-MAP2 (1:500), GFAP (1:500), AbOs-selective NU4 mouse monoclonal antibody (44 mg/ml) or anti-cytochrome c (1:1,000) was used. After this incubation period, fixed cultures were rinsed 3 times with PBS and incubated for 1 h at room temperature with Alexa Fluor 488 anti-rabbit, Alexa Fluor 635 anti-mouse, or Alexa Fluor 488 anti-sheep as secondary antibodies (1:400 in blocking solution). Cells were rinsed 3 times with PBS, and coverslips were mounted in ProLong or DAKO mounting medium. Cells were visualized on a Carl Zeiss LSM Pascal 5 confocal microscope system (Zeiss, Oberkochen, Germany), and images were digitally acquired by using LSM software (Zeiss). The ImageJ software program (National Institutes of Health, Baltimore, MD) was used for image deconvolution and generation of zeta projections from seven to15 stacks (0.4-mm thickness each). Quantitative analysis of immunofluorescence data was carried out with histogram analysis of the fluorescence intensity at each pixel across the image (after deconvolution) of a selected stack by using the ImageJ software.
Cell-viability assays
The viability of neuronal cultures was determined by using either the Live/Dead assay, as previously described (53) , or the MTT reduction assay. For the former assay, culture medium was removed, and cells were gently washed 3 times with PBS-glucose. Cells were then incubated at room temperature for 40 min with PBS-glucose containing 2 mM calcein-AM ester and 1 mM ethidium homodimer and were imaged with a Nikon Eclipse TE300 microscope. Live neurons were identified by their green calcein fluorescence and dead neurons by the red fluorescence of DNA-bound ethidium. Assays were carried out in triplicates with three independent neuronal cultures. Ten randomly chosen fields were examined per culture well, and about 500 cells were counted in each field per experimental condition. The percentage of live neurons was calculated relative to the total number of neurons observed in each field. Neuronal viability (mean AE SEM) is expressed as percentage of live cells relative to control cultures. When using the MTT assay, neuronal cultures were analyzed, as previously described. In brief, to allow MTT reduction to formazan blue by metabolically active cells, cultures were incubated for 4 h at 378C with MTT (0.5 mg/ml). Cells were then lysed, and formazan crystals were solubilized by overnight incubation at room temperature in 0.01N HCl containing 10% SDS. Optical density at 590 nm was measured in a ThermoMax Microplate reader.
Incubation of primary hippocampal cultures with AbOs
Unless otherwise indicated, neurons maintained in culture for 21 DIV were incubated with AbOs (500 nM) for 6 h. In these conditions, significant binding of AbOs to the soma and dendrites was observed ( Supplementary Fig. S2A ), with a similar punctate distribution, as previously reported (14) . Neurons incubated only with saline did not present bound AbOs ( Supplementary Fig. S2B ). 
Determination of intracellular
Determination of mitochondrial fragmentation
Primary cultures, fixed with formaldehyde as described earlier, were immunolabeled with mouse anti-mHsp70 (1:750) by incubation for 1 h at room temperature. Cultures were rinsed 3 times with PBS and incubated for 1 h at room temperature with Alexa Fluor 488 anti-mouse as secondary antibody (1:400 in blocking solution). After three rinses with PBS, coverslips were mounted in DAKO mounting medium. Confocal image stacks were captured with a Zeiss LSM-5, Pascal 5 Axiovert 200 microscope, by using LSM 5 3.2 image capture and analysis software and a Plan-Apochromat 40Â/ 1.4 Oil DIC objective. Image deconvolution was done with the Image J software, and z-stacks from images were reconstructed. The percentage of cells with a fragmented pattern was determined manually.
Additionally, we determined the association of the mitochondrial fission protein Drp-1 with mitochondria as a separate measure of enhanced mitochondrial fission. Mitochondrial extracts were prepared from 3 million cells for each condition, as previously described (51), and the content of Drp-1 present in these fractions was determined with Western blot analysis, as detailed later.
Determination of ATP cellular content
The CellTiter-GloTM luminescent assay kit (Promega, Madison, WI), based on ATP-dependent bioluminescence generation by luciferin/luciferase, was used to determine cellular ATP content. In brief, cells were seeded in a 96-well
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plate at a density of 9Â10 4 cells per well, and 45 ml of luminescent reagent (diluted 1:1 with PBS) was added to each well. After mixing and incubating for 10 min at room temperature, the ATP content was measured by using a Synergy 2 Biotek Model (Winooski, VT) plate reader.
Cytochrome c release
Cytochrome c release from mitochondria was detected with immunofluorescence by using confocal microscopy imaging. Cell cultures were fixed and immunostained for cytochrome c, as described earlier for other proteins. A punctate immunofluorescence indicates localization of cytochrome c to the mitochondria, whereas a diffuse pattern reflects cytochrome c release to the cytoplasm.
RNA isolation, PCR, and Western blot analysis
To extract RNA, cells were lysed as described in previous work (30) . Total RNA was isolated by using Trizol reagent. To remove any contaminating genomic DNA, a DNAase digestion step with Ambion DNA-free Kit was included. RNA purity was assessed by the 260/280 absorbance ratio, and RNA integrity, with gel electrophoresis. cDNA was synthesized from total RNA (1 mg) by using the ImProm-II Reverse Transcriptase kit. Twenty-five nanograms of cDNA was used in 20-ml final volume for PCR amplification (Applied Biosystems Thermal cycler). Amplification was performed by using the primers and conditions detailed in Supplementary  Table S1 . Real-time quantitative PCR (qRT-PCR) was performed in an amplification system (MX3000P; Stratagene, La Jolla, CA) by using the DNA-binding dye SYBR green. Levels of RyR mRNA were calculated with the relative 2-DDCt method (56) , and normalized with respect to levels of b-actin mRNA. Dissociation curves were analyzed to verify the purity of products. All samples were run at least in triplicate.
For Western blot analysis of RyR2 and RyR3, cells extracts prepared as described (37) were resolved by SDS-PAGE (3.5-8% gradient or 10% polyacrylamide gels, transferred to PDVF membranes and incubated overnight with specific antibodies against RyR2 or RyR3). To correct for loading, membranes were stripped and probed for b-actin. Microsomes isolated from canine heart or rat brain cortex (9) were used as positive controls for RyR2 and RyR3, respectively. For Western blot analysis of Drp-1, proteins were resolved by SDS-PAGE (12% polyacrylamide gels), transferred to PDVF membranes, and incubated overnight with specific antibodies against Drp-1 (1:1,000). To correct for loading, membranes were stripped and probed against the specific mitochondrial marker enzyme COX IV (1:1,000). The Scion Image USI program (National Institutes of Health) was used to quantify optical band density.
Analysis of dendritic spine morphology changes
Hippocampal cultures (21 DIV) were loaded for 20 min with 1 mM calcein-AM in Tyrode solution. Confocal fluorescence and optical differential interference contrast (DIC) images were obtained with a Zeiss LSM-5, Pascal 5 Axiovert 200 microscope, by using LSM 5 3.2 image capture and analysis software and a Plan-Apochromat 63Â/1.4 Oil DIC objective. We used the ImageJ software program (National Institutes of Health) for image deconvolution and generation of zeta projections from seven to 15 stacks (each 0.4-mm thickness). The 3D images were used simultaneously to identify and measure individual spines. To measure spine length, all spines in a single image plane were measured. Spine density in dendrites was analyzed by determining the number of spines present in a length of 100 mm; three to five dendrites were analyzed per condition in three independent experiments.
Statistics
Results are expressed as mean AE SEM. Unless otherwise indicated, statistical significance was evaluated by using the Student t test for paired data, and one-way or two-way ANOVA followed by Bonferroni's posttest for multiple determinations.
Results
Incubation of cultures for 6 h with 500 nM AbOs did not affect neuronal viability, assayed by Live/Dead cell staining, whereas incubation with 20 mM Ab fibrils was highly toxic ( Supplementary Fig. S2C ), as previously described (54) . Moreover, even 24-h incubation with 500 nM AbOs did not increase neuronal death, assayed with the MTT method ( Supplementary Fig. S2D ), confirming that 500 nM AbOs is a sublethal concentration (14) . In contrast, 24-h incubation with AbOs at concentrations ! 1 mM was significantly toxic to neurons, as was incubation with 50 mM N-methyl-d-aspartate (NMDA) or 50 mM glutamate used as positive controls of toxicity, which killed about 50% of neurons after 24 h of incubation ( Supplementary Fig. S2D ). Preincubation of cultures for 1 h with ryanodine (50 mM) did not protect against the enhanced neuronal death caused by subsequent incubation for 24 h with 1 mM AbOs, 50 mM NMDA, or 50 mM glutamate in the continuous presence of ryanodine, which by itself did not affect neuronal viability (Supplementary Fig. S2E ). These results suggest that factors other than RyR-mediated Ca 2þ release contribute to the neurotoxic effects of 1 mM AbOs, 50 mM NMDA, or 50 mM glutamate.
AbOs generate RyR-dependent Ca 2þ signals
Addition of 500 nM AbOs, which, as shown earlier, is within the sublethal concentration range, produced a rapid and sizable increase in neuronal cytoplasmic free [Ca 2þ ], measured with the fluorescent Ca 2þ indicator Fluo4-AM. As illustrated by a representative average fluorescence trace recorded from the soma of pyramidal neurons (Fig. 1A) , this [Ca 2þ ] increase lasted several minutes before slowly decaying back to resting levels; in this experiment, the addition of AbOs produced maximum values of (FÀF min )/(F max ÀF) ¼ 2.09 0.13 (mean AE SEM, n ¼ 5). The increase in intracellular [Ca 2þ ] caused by AbOs, which was consistently observed in 13 independent cultures, was suppressed by 1-h preincubation with 50 mM ryanodine added as a selective inhibitor of RyRmediated Ca 2þ release (Fig. 1B) . Partial neuronal depolarization by addition of 20 mM KCl to primary cultures treated with AbOs (Fig. 1B inset, arrow) or to cultures preincubated with ryanodine and treated with AbOs (Fig. 1B, arrow) produced a small but significant [Ca 2þ ] increase in pyramidal cell soma, showing that ryanodine did not affect voltage-gated Ca 2þ channels. Preincubation for 30 min with 10 mM MK-801 to inhibit NMDA receptors (NMDARs) also suppressed the Ca 2þ increase induced by AbOs (Fig. 1C) , as did removal of (Fig. 1D) . Preincubation for 30 min with 100 mM BAPTA-AM to chelate intracellular Ca 2þ also suppressed, after some delay, the initial increase in intracellular [Ca 2þ ] caused by AbOs (Fig. 1E ), whereas preincubation with 10 mM N-acetyl-l-cysteine (NAC) for 1 h abolished the [Ca 2þ ] increase produced by AbOs (Fig. 1F) .
To verify the effectiveness of 50 mM ryanodine in suppressing RyR-mediated Ca 2þ release activity, we added 1 mM 4-cloro-methyl-cresol (4-CMC) to cultures loaded with Fluo4-AM. This RyR agonist produced a sizeable and sustained [Ca 2þ ] increase in the soma of control neurons but not in neurons preincubated with ryanodine, which did respond, however, to subsequent addition of 20 mM KCl (Supplementary Fig. S3A ). Moreover, both control neurons and neurons preincubated with 50 mM ryanodine displayed a similar fluorescence increase after addition of 20 mM KCl, but the signal lasted significantly longer in control neurons ( Supplementary Fig. S3B ). These results show that that 50 mM ryanodine did not impair depolarization-induced Ca 2þ entry but prevented the sustained phase of this response, suggesting that this delayed response takes place via RyR-mediated CICR. In addition, the stimulation of RyR-mediated Ca 2þ release by 4-CMC was completely prevented by preincubation of primary cultures with 10 mM NAC for 60 min (Supplementary Fig. S3C ). These results confirm that reducing agents prevent agonist-induced RyR activation in neurons (10) .
Altogether, these results strongly suggest that stimulation of NMDAR-dependent Ca 2þ entry by AbOs triggers RyRmediated CICR in the oxidative intracellular environment produced by AbOs, which originates the persistent cytoplasmic [Ca 2þ ] increase observed after AbOs addition.
RyR inhibition prevents the neuronal mitochondrial fragmentation induced by AbOs
Confocal microscopy analysis revealed that 97% of primary hippocampal neurons contain elongated tubular mitochondria, exhibiting filamentous morphology of variable length in neuronal projections and the cell body ( Fig. 2A) . In contrast, 55% of neurons treated for 24 h with AbOs (500 nM) exhibited mitochondria with punctate morphology, revealing significant fragmentation of filamentous mitochondria (Fig. 2B) . Incubation of cultures with 50 mM ryanodine for 4 h previous to AbOs addition significantly reduced (from 55% to 14%) the fraction of neurons exhibiting fragmented mitochondria (Fig. 2C) , whereas neurons in cultures incubated with 50 mM ryanodine in the absence of AbOs had a content (97%) of elongated mitochondrial networks similar to that of controls (Fig. 2D) .
Incubation of primary hippocampal cultures for only 6 h with 500 nM AbOs also induced noticeable mitochondrial fragmentation (data not shown), whereas incubation for 24 h with 1 mM AbOs, which decreased cell viability (Supplementary Fig. S2 ), produced even more mitochondrial fragmentation than did incubation with 500 nM AbOs for 24 h (data not shown).
To confirm that AbOs stimulated mitochondrial fragmentation, we detected in immunoblots the content of the fission protein Drp-1 in mitochondrial-enriched fractions isolated from control cultures of from cultures incubated with 500 nM AbOs for 24 h. As illustrated in Fig. 2E , Drp-1 was highly enriched in the mitochondrial fraction isolated from cultures incubated with AbOs compared with the controls. Furthermore, this sublethal concentration of AbOs did not impair mitochondrial ATP production or cause cytochrome c release ( Supplementary Fig. S4 ). These results indicate that the mitochondrial fragmentation induced by AbOs did not produce substantial mitochondrial damage.
These combined results suggest that RyR-mediated Ca 2þ release plays a major role in the mitochondrial network fragmentation induced by sublethal concentrations of AbOs.
AbOs downregulate RyR expression
Our observations suggest that RyR-mediated Ca 2þ release is an early event triggered by AbOs. To define the possible impact of AbOs on RyR regulation, we examined RyR expression and localization in cells exposed to sublethal concentrations of AbOs. Immunofluorescence experiments revealed that incubation with 500 nM AbOs for 6 h, but not for 24 h, decreased the RyR2 protein content in both cell soma and neurites (Fig. 3) , whereas RyR3 protein levels were not affected (data not shown). In agreement with these results, incubation with AbOs (500 nM) significantly decreased RyR2 mRNA levels after 6 h, and RyR3 mRNA after 12 h, and these levels remained reduced for up to 24 h (Fig. 4A) . Western blot analysis revealed that AbOs also significantly reduced RyR2 protein content to 33% (AE11%) of control after 1 h and to 44% (AE3%) after 6 h (n ¼ 12). Interestingly, these effects were transient, as RyR2 protein content was 113% (AE6%) and 112% (AE14%) of control after 12 h and 24 h of incubation with AbOs, respectively (Fig. 4B) . In contrast, except for the small increase observed after 24 h, incubation with AbOs did not produce significant changes in RyR3 protein content (Fig. 4B) . The RyR1 isoform was not detected in immunoblots when using antibodies that readily detect RyR1 in skeletal muscle microsomes (data not shown).
Ryanodine addition (50 mM) to cultures 1 h before AbOs provided significant, albeit partial, protection against the reduction of RyR2 protein content caused by incubation with 500 nM AbOs for 6 h (Fig. 5A) . Preincubation with the NMDAR inhibitor MK-801 (10 mM) completely abolished the reduction of RyR2 protein promoted by subsequent addition of AbOs (Fig. 5B) . These results show that functional NMDAR and RyR-mediated Ca 2þ signals participate in the cellular pathways that cause downregulation of RyR2 by AbOs.
AbOs prevent increased RyR2 expression and dendritic spine remodeling induced by BDNF
Preincubation of primary cultures for 1 h with 200 nM AbOs completely prevented the increase in RyR2 mRNA levels (Fig. 6A ) and protein content (Fig. 6B) produced by subsequent incubation with BDNF (50 ng/ml) for 6 h. In addition, neurons incubated with BDNF for 6 h displayed a significant increase in spine density compared with the controls (Fig. 7A) . Quantification of net changes revealed that BDNF increased spine density to values 1.4 AE 0.11 higher than controls (Fig. 7B) . Addition of 500 nM AbOs 1 h before BDNF addition produced a drastic decrease in spine density (Fig.   7A ) that reached values of 0.65 AE 0.1 compared with control neurons (Fig. 7B) .
Addition of BDNF produced within minutes a significant increase in the length of preexistent spines (Fig. 7C, solid  circles) and prompted the formation of new spines in control neurons, as illustrated by the images shown at the right, taken 60 min after BDNF addition. This spine remodeling did not occur after addition of BDNF to neurons preincubated with 500 nM AbOs for 6 h (Fig. 7C, solid squares) . In contrast, neurons preincubated with 500 nM AbOs for 24 h displayed significant increases in spine length after the addition of BDNF (Fig. 7C, solid triangles) , albeit at a slower rate than that displayed by control neurons after BDNF addition. Control neurons incubated with caffeine (10 mM), a well-known RyR The error between controls in each experiment was <0.25. Statistical analysis was performed with the one-sample t test comparing column data against the hypothetical value of 1. *p < 0.05; **p < 0.01; and ***p < 0.001. (B) Representative Western blots for RyR2 and RyR3 in neurons treated with 500 nM AbOs for 6 or 24 h. Quantitative analysis of the timecourse changes in the levels of RyR2 and RyR3 protein expression induced by AbOs, normalized to b-actin. Results are expressed as mean AE SEM (n ! 3). Statistical significance was analyzed with ANOVA and the Bonferroni posttest. *p < 0.05; ***p < 0.001.
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agonist that promotes RyR-dependent spine growth (39), also exhibited significant spine elongation 45 min after caffeine addition (Fig. 7D, solid circles) . Significantly, preincubation with AbOs (500 nM) for 6 h abolished the spine-length increases induced by caffeine (Fig. 7D, solid squares) . On the whole, these combined results suggest that inhibition of BDNF-induced RyR expression and spine remodeling may contribute to the synaptic plasticity defects induced by AbOs.
Discussion
The results presented here show for the first time that exposure of primary hippocampal neurons to sublethal concentrations of AbOs, the synaptotoxic soluble Ab aggregates implicated in AD pathology, generated RyR-mediated Ca functional NMDAR (14) . Adding to these previous studies, our findings indicate for the first time that RyR-mediated Ca 2þ release is the primary source of the sustained Ca 2þ signals generated by AbOs, because they were abolished by selective RyR inhibition. (A) Representative images of dendritic spines in control neurons, in neurons exposed to BDNF for 6 h, and in neurons preincubated with 500 nM AbOs for 1 h before loading with calcein and subsequently treated with BDNF (50 ng/ml). Scale bar, 5 mm. (B) Quantification of changes in spine density. Results represent mean AE SEM (n ¼ 3-6). Statistical significance was analyzed with one-way ANO-VA, followed by the Bonferroni posttest. *p < 0.05; **p < 0.01. (C) Left: Quantification of net changes in spine length in control neurons (empty squares, n ¼ 8), in neurons exposed to 50 ng/ml BDNF (solid circles, n ¼ 10), and in neurons preincubated with 500 nM AbOs for 6 h (solid squares, n ¼ 4) or for 24 h (solid triangles, n ¼ 13) before calcein loading and before addition of BDNF. Results represent mean AE SEM. Statistical significance was analyzed with two-way ANOVA, followed by the Bonferroni posttest.
*p < 0.05; **p < 0.01; ***p < 0.001, statistically significantly different from control; ### p < 0.001 relative to BDNF-treated neurons. Right: Fluorescent confocal images of a neurite from a neuron stimulated for 60 min with BDNF (50 ng/ml); spine elongation and formation of a new spine can be appreciated. Incubation with 500 nM AbOs for 6 h before calcein loading prevented the dendritic-spine changes induced by BDNF, whereas spines from neurons preincubated with 500 nM AbOs for 24 h displayed slower but significant increases in length after addition of BDNF. Scale bar, 2 mm. (D) Left: Quantification of net changes in spine length in control neurons (open squares, n ¼ 8), in neurons exposed to 10 mM caffeine (solid circles, n ¼ 25), and in neurons preincubated with 500 nM AbOs for 6 h (solid squares, n ¼ 23) before calcein loading and subsequent addition of BDNF. Results represent mean AE SEM. Statistical significance was analyzed with two-way ANOVA, followed by the Bonferroni posttest. **p < 0.01; ***p < 0.001, statistically significant difference from control. Right: Fluorescent confocal images of a neurite from a neuron stimulated for 60 min with caffeine (10 mM); spine elongation is observed. Incubation with 500 nM AbOs for 6 h before calcein loading prevented the dendritic-spine changes induced by caffeine. Scale bar, 2 mm.
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PAULA-LIMA ET AL. ], such as that induced by AbOs, is likely to promote an increase in mitochondrial Ca 2þ , a condition that promotes mitochondrial fragmentation (32, 34) . It has been reported that AbOs (500 nM) increased within minutes the mitochondrial Ca 2þ in cerebellar granule cells, whereas release of cytochrome c and apoptosis occurred only after 72 h of incubation with AbOs (62) .
In rat primary hippocampal neurons, APP overexpression induces mitochondrial fragmentation, probably through increased Ab peptide production (75) , whereas treatment for 24 h with AbOs (800 nM) also produces loss of dendritic spines, in addition to mitochondrial fragmentation (74) . These combined reports, plus our own results, suggest that increased mitochondrial fission, likely due to mitochondrial Ca 2þ overload produced by the prolonged RyR-mediated Ca 2þ signals generated by AbOs, may contribute to mitochondrial and neuronal dysfunction in AD brain.
RyR expression
Hippocampal neurons express RyR in axons, dendrites, and dendritic spines, whereas IP3 receptors are expressed throughout hippocampal cells but not in dendritic spines (64) . Our results indicate that the RyR2 and RyR3 isoforms are abundantly present in cell bodies and neurites of primary hippocampal neurons. In addition, we show that incubation with AbOs for 6 h produced a transient decrease in RyR2 protein expression in these neurons without affecting RyR3.
Our results showing decreased RyR2 expression in neurons treated with AbOs, even after treatment with BDNF, agree well with a previous report describing that AD human cortex displays reduced RyR2 protein content and decreased [ 3 H]-ryanodine binding, a likely consequence of decreased RyR2 content (36) . Given the prominent role played by RyR-mediated Ca 2þ signals in synaptic transmission and neuronal plasticity (4, 19, 22, 33, 39, 45) , a decrease in RyR2 expression may contribute to the defective synaptic plasticity produced by AbOs. Moreover, hippocampal expression of the RyR2 isoform increases after spatial memory training (77) , and selective RyR2 and RyR3 knockdown with antisense oligonucleotides impairs memory processes (22) . Accordingly, by transiently decreasing RyR2 expression, among other effects, AbOs may impair hippocampal memory formation.
Our in silico analysis revealed that the published rat RyR2 gene sequence contains response elements to the Ca 2þ -activated transcriptional regulators CREB and NFAT. These regulators may respond to RyR-mediated Ca 2þ signals induced by AbOs, generating changes in expression of RyR2 and other proteins. The finding that RyR inhibition partially protected against the decrease in RyR2 expression produced by AbOs supports the involvement of RyR-mediated Ca 2þ signals in this decrease. It is worth mentioning in this context that tissue from AD brains displays significant downregulation of neuronal calcineurin (11), a Ca 2þ -activated phosphatase known to play fundamental roles in synaptic plasticity and long-term depression (LTD). Yet, incubation of human SY5Y neuroblastoma cells with AbOs for 3 h significantly increases calcineurin activity, leading to decreased CREB phosphorylation and CREB-driven transcriptional activity (59) . Moreover, calcineurin and AbOs jointly decrease CREB phosphorylation (68) . A decrease in CREB phosphorylation may underlie the reduction in RyR2 expression produced by AbOs, even after BDNF addition. Future studies should address how prolonged RyR-mediated Ca 2þ signals induced by AbOs, which can be prevented by inhibition of NMDAR activity, stimulate pathways that downregulate hippocampal RyR2 expression, and should also address whether these signals contribute to activate calcineurin-mediated LTD during the progression of AD.
Synaptic spine remodeling
Hippocampal synaptic plasticity requires significant postsynaptic remodeling, which entails the generation and growth of dendritic spines (38) . Significantly, incubation with AbOs for a period of 6 h prevented the rapid spine remodeling prompted by caffeine-induced RyR-mediated Ca 2þ release (39) or by BDNF, which also requires RyR-mediated Ca 2þ signals (1). These results strongly suggest that the transient RyR2 decrease induced by AbOs (6 h) produces a significant reduction of RyR2-mediated Ca 2þ signals in response to BDNF, leading to defective synaptic remodeling in primary hippocampal neurons. In contrast, RyR2 expression and BDNF-induced spine remodeling were similar to the controls after longer incubation (24 h) with AbOs. These findings suggest that primary hippocampal neurons possess mechanisms to compensate for the significant short-term loss of RyR2 produced by AbOs. Moreover, incubation with AbOs for 24 h produced a small (23%) but significant increase in RyR3 protein content, which may contribute to producing the Ca 2þ signals that underlie BDNF-induced spine remodeling. Previous reports indicate that AbOs downregulate BDNF expression (55) and interfere with BDNF-induced signaling pathways that include Ca 2þ -dependent kinase pathways that enhance CREB phosphorylation (68) . AbOs also decrease rapidly the NMDAR and EphB2 receptor expression in the plasma membrane, followed by the development of abnormal dendritic spine morphology and spine degeneration (41) . These factors, plus the present findings showing that AbOs transiently decreased RyR2 protein expression, prevented the RyR2-expression enhancement and spine-morphology changes induced by BDNF and induced mitochondrial fission, may act in conjunction to provoke the strong synaptotoxicity caused by AbOs.
Concluding Remarks
The hippocampus is a brain structure specifically associated with memory formation that is severely affected early in the course of AD (18). In normal brain, long-lasting synaptic plasticity (49) and hippocampal memory formation (2) require extensive synaptic spine remodeling, which is made possible by changes in gene transcription and the ensuing protein synthesis (6, 21, 76) . The present results demonstrate that AbOs rapidly generated prolonged RyR-mediated Ca 2þ signals. We propose that, by engaging Ca 2þ -dependent pathways, these signals may cause the observed decrease in RyR2 expression that presumably contributes to suppress the RyR-dependent spine growth induced by BDNF. Downregulation of RyR2 expression, which occurred even in neurons treated with BDNF, in addition to the partly RyRdependent mitochondrial fragmentation caused by AbOs, may contribute to produce the hippocampal synaptotoxicity and defective synaptic plasticity induced by soluble Ab oligomers in AD.
